The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Catch Some Zs

Catch Some Zs

April 1, 2008 • By Virginia Hughes

  • Tweet
  • Email
Print-Friendly Version / Save PDF

BOSTON—Most American adults don’t get enough sleep. According to the National Institutes of Health, an estimated 30% of adults report some kind of sleep disturbance. Ten percent have chronic insomnia—and with it, pain, fatigue, mood swings, or memory problems. Sleep may be especially elusive for those with rheumatic disease. As many as 80% of these patients have sleeping problems, and half suffer from chronic insomnia.

You Might Also Like
  • Knee Osteoarthritis Pain Worse with Insomnia
  • Poor Sleep Associated with Higher Risk of Chronic Pain
  • Sleep Tips for RA Patients & Rheumatologists
Explore This Issue
April 2008
Also By This Author
  • Rheumatology Goes to Washington

In the last few years, many people with sleep disturbances have turned to new prescription drugs to fix the problem. (Ambien, which accounts for about 60% of all sleeping-pill prescriptions in the U.S., accounted for $2.8 billion in sales last year, according to IMS Health.) But these pills often come with side effects including dizziness, nausea, and—most commonly—feelings of “drugged drowsiness” during the day.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Cognitive behavioral therapies (CBTs)—in which patients modify their day- and nighttime habits in order to restore normal sleeping patterns—have been shown to be useful alternatives to pharmacological treatments. “Virtually all insomnias have a learned component,” says Pamela Degotardi, PhD, a developmental psychologist at Queens College in New York City. “CBT teaches strategies to change these learned behaviors.” Dr. Degotardi joined clinical psychologist Diana G. Fox, PsyD, also of Queens College, to lead the session titled “Improving Sleep: Non-Pharmacological Strategies” at the ACR/ARHP Annual Scientific Meeting in Boston last November.

The consequences of chronic insomnia can be debilitating. In one 2005 study, Dr. Fox points out, patients with chronic insomnia had problems performing tasks that measured vigilance, working memory, and motor control. Moreover, they self-reported negative moods and difficulty concentrating. A meta-analysis of studies that used subjects who were sleeping less than five hours a night on a regular basis found that these people had decreased glucose tolerance, increased blood pressure, reduced levels of leptin (an appetite-reducing hormone), and increased inflammatory markers. For those subjects who had poor sleeping patterns for six years or more, the study found a 15% increase in all-cause mortality—even after they had controlled for other risk factors like blood pressure and body mass index.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Identify Causes of Sleeplessness

Rather than focusing on the unfortunate consequences of chronic sleeping problems, the two experts stress treatment strategies. “The first step is assessing what exactly the sleeping problem is,” says Dr. Degotardi. The most effective way to do so, she adds, is with a thorough clinical interview. Doctors should ask these patients about their daily routine and typical sleep schedule—when they get to bed, when they wake up, how many naps they take, and whether any of this shifts dramatically on the weekends. They should ask how long it typically takes to fall asleep, if patients have frequent awakenings during the night, and if they can fall back to sleep after these disturbances.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: Clinical research, insomnia, National Institutes of Health, Sleep, Sleep StrategiesIssue: April 2008

You Might Also Like:
  • Knee Osteoarthritis Pain Worse with Insomnia
  • Poor Sleep Associated with Higher Risk of Chronic Pain
  • Sleep Tips for RA Patients & Rheumatologists
  • Tips for Treating Insomnia in Rheumatology Patients

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)